[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 396,117
  • Shares Outstanding, K 109,123
  • Annual Sales, $ 0 K
  • Annual Income, $ -223,120 K
  • EBIT $ -232 M
  • EBITDA $ -220 M
  • 60-Month Beta 0.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.43

Options Overview Details

View History
  • Implied Volatility 133.97% (-83.09%)
  • Historical Volatility 83.69%
  • IV Percentile 40%
  • IV Rank 7.42%
  • IV High 577.24% on 06/30/25
  • IV Low 98.46% on 09/18/25
  • Expected Move (DTE 4) 0.95 (26.23%)
  • Put/Call Vol Ratio 0.14
  • Today's Volume 107
  • Volume Avg (30-Day) 384
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 16,112
  • Open Int (30-Day) 29,619
  • Expected Range 2.68 to 4.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.41
  • Number of Estimates 4
  • High Estimate $-0.35
  • Low Estimate $-0.49
  • Prior Year $-0.59
  • Growth Rate Est. (year over year) +30.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.31 +9.67%
on 04/29/26
4.10 -11.46%
on 04/17/26
+0.03 (+0.83%)
since 04/08/26
3-Month
3.07 +18.43%
on 02/09/26
5.45 -33.39%
on 03/10/26
+0.47 (+14.87%)
since 02/06/26
52-Week
2.19 +65.75%
on 05/27/25
7.39 -50.88%
on 05/12/25
-3.41 (-48.44%)
since 05/08/25

Most Recent Stories

More News
Rocket Pharmaceuticals: Q1 Earnings Snapshot

Rocket Pharmaceuticals: Q1 Earnings Snapshot

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Pivotal Phase 2 trial of RP-A501 for Danon disease progressing with dosing reinitiated First patient dosing in Phase 1 study of RP-A701 for BAG3-related dilated cardiomyopathy...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

PRV monetization provides $180 million in non-dilutive capital to support cardiovascular pipeline Cash runway extended into the second quarter of 2028

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals Announces FDA Approval of KRESLADIâ„¢ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)

First FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2 Severe LAD-I is an ultra-rare, life-threatening pediatric genetic immunodeficiency...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals: Q4 Earnings Snapshot

Rocket Pharmaceuticals: Q4 Earnings Snapshot

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress

Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026 KRESLADI â„¢ for severe LAD-I on track for March 28, 2026 PDUFA date ...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need,...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need,...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need,...

RCKT : 3.63 (-1.09%)
Rocket Pharmaceuticals: Q3 Earnings Snapshot

Rocket Pharmaceuticals: Q3 Earnings Snapshot

RCKT : 3.63 (-1.09%)

Business Summary

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States....

See More

Key Turning Points

3rd Resistance Point 4.31
2nd Resistance Point 4.14
1st Resistance Point 3.88
Last Price 3.63
1st Support Level 3.45
2nd Support Level 3.28
3rd Support Level 3.02

See More

52-Week High 7.39
Fibonacci 61.8% 5.40
Fibonacci 50% 4.79
Fibonacci 38.2% 4.18
Last Price 3.63
52-Week Low 2.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.